Print

PolyMedix Inc. (PYMX.OB) Defensin-Mimetic Anti-Malaria Data Published in Cell Host and Microbe  
1/14/2013 8:42:27 AM

RADNOR, Pa., Jan. 14, 2013 (GLOBE NEWSWIRE) -- PolyMedix, Inc. (OTCBB:PYMX), a biotechnology company dedicated to developing novel treatments for infectious diseases with defensin-mimetic antimicrobial agents, today announced that pre-clinical data demonstrating activity of the Company's defensin-mimetic antimicrobial compounds against the parasite that causes malaria, Plasmodium falciparum, were published in the December issue of Cell Host and Microbe, a peer-reviewed scientific journal.
//-->